Quest Diagnostics Inc Goodwill, Period Increase (Decrease)
Quest Diagnostics Inc (DGX) reported Goodwill, Period Increase (Decrease) of $9.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Goodwill and Other
us-gaap:GoodwillPeriodIncreaseDecrease · last filed 2026-02-26
- Quest Diagnostics Inc goodwill, period increase (decrease) for the quarter ending 2022-12-31 was $6.00M.
- Quest Diagnostics Inc goodwill, period increase (decrease) for the quarter ending 2022-09-30 was -$5.00M.
- Quest Diagnostics Inc goodwill, period increase (decrease) for the quarter ending 2022-06-30 was -$3.00M, a 400.00% decline year-over-year.
- Quest Diagnostics Inc goodwill, period increase (decrease) for the quarter ending 2022-03-31 was $6.00M.
- Quest Diagnostics Inc goodwill, period increase (decrease) for fiscal 2025 was $9.00M.
- Quest Diagnostics Inc goodwill, period increase (decrease) for fiscal 2024 was -$23.00M, a 1250.00% decline from fiscal 2023.
- Quest Diagnostics Inc goodwill, period increase (decrease) for fiscal 2023 was $2.00M, a 50.00% decline from fiscal 2022.
- Quest Diagnostics Inc goodwill, period increase (decrease) for fiscal 2022 was $4.00M.
| Period end | Goodwill, Period Increase (Decrease) 3 month | Goodwill, Period Increase (Decrease) 6 month | Goodwill, Period Increase (Decrease) 9 month | Goodwill, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $9.00M 10-K · filed 2026-02-26 | |||
| 2024-12-31 | -$23.00M 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $2.00M 10-K · filed 2025-02-20 | |||
| 2022-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $1.00M derived: sum of 2 quarters · filed 2024-02-22 | -$2.00M derived: sum of 3 quarters · filed 2024-02-22 | $4.00M 10-K · filed 2024-02-22 |
| 2022-09-30 | -$5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-21 | -$8.00M derived: sum of 2 quarters · filed 2022-10-21 | -$2.00M 10-Q · filed 2022-10-21 | -$4.00M derived: sum of 4 quarters · filed 2023-02-21 |
| 2022-06-30 | -$3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-22 | $3.00M 10-Q · filed 2022-07-22 | $1.00M derived: sum of 3 quarters · filed 2023-02-21 | -$1.00M derived: sum of 4 quarters · filed 2023-02-21 |
| 2022-03-31 | $6.00M 10-Q · filed 2022-04-22 | $4.00M derived: sum of 2 quarters · filed 2023-02-21 | $2.00M derived: sum of 3 quarters · filed 2023-02-21 | $3.00M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | -$4.00M derived: sum of 2 quarters · filed 2023-02-21 | -$3.00M derived: sum of 3 quarters · filed 2023-02-21 | -$6.00M 10-K · filed 2023-02-21 |
| 2021-09-30 | -$2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-22 | -$1.00M derived: sum of 2 quarters · filed 2021-10-22 | -$4.00M 10-Q · filed 2021-10-22 | $0.00 derived: sum of 4 quarters · filed 2022-02-28 |
| 2021-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-23 | -$2.00M 10-Q · filed 2021-07-23 | $2.00M derived: sum of 3 quarters · filed 2022-02-28 | $5.00M derived: sum of 4 quarters · filed 2022-02-28 |
| 2021-03-31 | -$3.00M 10-Q · filed 2021-04-23 | $1.00M derived: sum of 2 quarters · filed 2022-02-28 | $4.00M derived: sum of 3 quarters · filed 2022-02-28 | $6.00M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $7.00M derived: sum of 2 quarters · filed 2022-02-28 | $9.00M derived: sum of 3 quarters · filed 2022-02-28 | $7.00M 10-K · filed 2022-02-28 |
| 2020-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-23 | $5.00M derived: sum of 2 quarters · filed 2020-10-23 | $3.00M 10-Q · filed 2020-10-23 | $4.00M derived: sum of 4 quarters · filed 2021-02-22 |
| 2020-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-24 | $0.00 10-Q · filed 2020-07-24 | $1.00M derived: sum of 3 quarters · filed 2021-02-22 | |
| 2020-03-31 | -$2.00M 10-Q · filed 2020-05-04 | -$1.00M derived: sum of 2 quarters · filed 2021-02-22 | ||
| 2019-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $13.00M 10-K · filed 2021-02-22 | ||
| 2019-09-30 | $12.00M 10-Q · filed 2019-10-23 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |